共 104 条
- [1] Zuberbier T(2014)The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update Allergy 69 868-87
- [2] Aberer W(2011)Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report Allergy 66 317-30
- [3] Asero R(2010)Epidemiology of urticaria: a representative cross-sectional population survey Clin Exp Dermatol 35 869-73
- [4] Maurer M(2015)Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study J Invest Dermatol 135 67-75
- [5] Weller K(2013)Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy J Allergy Clin Immunol 132 101-9
- [6] Bindslev-Jensen C(2013)Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria N Engl J Med 368 924-35
- [7] Zuberbier T(2014)Subtypes of chronic urticaria in patients attending allergy clinics in Venezuela Eur Ann Allergy Clin Immunol 46 210-5
- [8] Balke M(2012)The urticarias: pathophysiology and management Clin Med (Lond) 12 164-7
- [9] Worm M(2009)The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations Allergy 64 1715-21
- [10] Edenharter G(2015)Management and treatment of chronic urticaria (CU) J Eur Acad Dermatol Venereol 29 16-32